Fernándo González-Ortiz

Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring

Sterling C. Johnson, Alexa Pichet Binette, K. Blennow, 2022, Nature Medicine.

Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications

K. Blennow, H. Zetterberg, T. Karikari, 2023, Molecular Neurodegeneration.

Diagnostic value of serum versus plasma phospho-tau for Alzheimer’s disease

K. Blennow, E. Vanmechelen, H. Zetterberg, 2022, Alzheimer's research & therapy.

Plasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays

K. Blennow, E. Vanmechelen, H. Zetterberg, 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Brain-derived tau: a novel blood-based biomarker for Alzheimer’s disease-type neurodegeneration

K. Blennow, Douglas Galasko, H. Zetterberg, 2022, Brain : a journal of neurology.